ProShare Advisors’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-30,949
| Closed | -$584K | – | 1831 |
|
|
2019
Q3 | $584K | Buy |
30,949
+385
| +1% | +$7.27K | ﹤0.01% | 925 |
|
|
2019
Q2 | $360K | Sell |
30,564
-2,881
| -9% | -$33.9K | ﹤0.01% | 1151 |
|
|
2019
Q1 | $457K | Buy |
33,445
+4,143
| +14% | +$56.6K | ﹤0.01% | 1048 |
|
|
2018
Q4 | $300K | Sell |
29,302
-5,652
| -16% | -$57.9K | ﹤0.01% | 1156 |
|
|
2018
Q3 | $582K | Sell |
34,954
-1,233
| -3% | -$20.5K | ﹤0.01% | 1041 |
|
|
2018
Q2 | $572K | Sell |
36,187
-3,283
| -8% | -$51.9K | ﹤0.01% | 1051 |
|
|
2018
Q1 | $501K | Sell |
39,470
-6,446
| -14% | -$81.8K | ﹤0.01% | 1095 |
|
|
2017
Q4 | $526K | Buy |
45,916
+3,419
| +8% | +$39.2K | ﹤0.01% | 1108 |
|
|
2017
Q3 | $521K | Buy |
42,497
+12,452
| +41% | +$153K | ﹤0.01% | 948 |
|
|
2017
Q2 | $344K | Sell |
30,045
-2,251
| -7% | -$25.8K | ﹤0.01% | 1101 |
|
|
2017
Q1 | $672K | Sell |
32,296
-8,457
| -21% | -$176K | 0.01% | 895 |
|
|
2016
Q4 | $848K | Buy |
40,753
+3,805
| +10% | +$79.2K | 0.01% | 851 |
|
|
2016
Q3 | $1.21M | Sell |
36,948
-5,978
| -14% | -$196K | 0.02% | 629 |
|
|
2016
Q2 | $1.07M | Buy |
42,926
+7,675
| +22% | +$192K | 0.01% | 693 |
|
|
2016
Q1 | $863K | Sell |
35,251
-3,225
| -8% | -$79K | 0.01% | 756 |
|
|
2015
Q4 | $1.27M | Buy |
38,476
+3,058
| +9% | +$101K | 0.02% | 652 |
|
|
2015
Q3 | $1.16M | Buy |
35,418
+2,493
| +8% | +$81.7K | 0.02% | 630 |
|
|
2015
Q2 | $1.74M | Buy |
32,925
+443
| +1% | +$23.5K | 0.02% | 556 |
|
|
2015
Q1 | $937K | Buy |
32,482
+10,361
| +47% | +$299K | 0.01% | 873 |
|
|
2014
Q4 | $643K | Buy |
+22,121
| New | +$643K | 0.01% | 1086 |
|